Inhibikase Therapeutics Inc
|
|
N/A
|
5.1M
$16.6B
|
|
|
|
$24.61 - $33.18
$12.6M - $17M
|
1.05M
$27.4B
|
|
|
|
$91.29 - $91.8
$10M - $10.1M
|
132K
$12B
|
|
|
|
$11.16 - $12.71
$5.39M - $6.14M
|
3.51M
$41.5B
|
|
Anteris Technologies Global
|
|
N/A
|
1.05M
$5.88B
|
|
|
|
N/A
|
5.63M
$5.48B
|
|
|
|
$42.97 - $60.6
$5.4M - $7.61M
|
170K
$7.44B
|
|
|
|
N/A
|
1.51M
$11.1B
|
|
Oaktree Acquisition Corp Iii
|
|
N/A
|
500K
$5.07B
|
|
|
|
$45.89 - $57.31
$4.57M - $5.71M
|
99.6K
$4.8B
|
|
|
|
N/A
|
8M
$4.36B
|
|
|
|
$7.03 - $10.05
$3.58M - $5.11M
|
515K
$4.03B
|
|
|
|
$104.54 - $137.94
$3.44M - $4.54M
|
40K
$4.86B
|
|
|
|
N/A
|
4.5M
$3.86B
|
|
|
|
$28.4 - $31.34
$2.5M - $2.76M
|
211K
$6.59B
|
|
|
|
N/A
|
130K
$2.86B
|
|
|
|
$11.35 - $18.82
$2.35M - $3.9M
|
211K
$2.66B
|
|
|
|
$1.99 - $2.79
$1.62M - $2.27M
|
928K
$2.46B
|
|
|
|
$15.04 - $18.67
$1.97M - $2.44M
|
154K
$2.58B
|
|
A Spac Iii Acquisition Corp
|
|
N/A
|
215K
$2.17B
|
|
|
|
N/A
|
2M
$2.1B
|
|
|
|
$0.81 - $3.1
$945K - $3.62M
|
1.17M
$1.86B
|
|
Palvella Therapeutics Inc Ne
|
|
N/A
|
145K
$1.74B
|
|
|
|
$46.91 - $67.33
$1.45M - $2.08M
|
30.9K
$1.73B
|
|
|
|
$83.08 - $100.49
$1.58M - $1.92M
|
19.7K
$1.66B
|
|
|
|
$4.21 - $5.9
$1.46M - $2.04M
|
648K
$3.23B
|
|
Mineralys Therapeutics Inc
|
|
N/A
|
842K
$10.4B
|
|
|
|
$8.32 - $12.64
$985K - $1.5M
|
149K
$1.8B
|
|
|
|
$9.96 - $12.36
$1.2M - $1.48M
|
120K
$1.48B
|
|
|
|
$34.99 - $52.07
$981K - $1.46M
|
48K
$2.17B
|
|
|
|
$2.37 - $9.6
$318K - $1.29M
|
134K
$1.29B
|
|
|
|
$16.43 - $22.77
$633K - $877K
|
147K
$3.23B
|
|
|
|
$66.29 - $76.63
$1.22M - $1.41M
|
22K
$1.52B
|
|
|
|
N/A
|
204K
$1.2B
|
|
|
|
N/A
|
36.8K
$1.66B
|
|
|
|
N/A
|
445K
$1.4B
|
|
|
|
$40.18 - $66.83
$744K - $1.24M
|
31.5K
$1.69B
|
|
|
|
$28.71 - $47.02
$548K - $898K
|
29.1K
$1.35B
|
|
Contineum Therapeutics Inc
|
|
N/A
|
82.2K
$1.2B
|
|
Structure Therapeutics Inc
|
|
N/A
|
35.3K
$958M
|
|
|
|
$226.16 - $274.52
$905K - $1.1M
|
4K
$918M
|
|
|
|
$38.14 - $45.74
$864K - $1.04M
|
50.5K
$1.98B
|
|
|
|
N/A
|
216K
$6.19B
|
|
|
|
$7.07 - $45.73
$53.1K - $343K
|
19.5K
$843M
|
|
Neumora Therapeutics Inc.
|
|
N/A
|
68.6K
$727M
|
|
|
|
$2.97 - $4.84
$417K - $680K
|
196K
$922M
|
|
|
|
N/A
|
123K
$712M
|
|
|
|
$232.27 - $300.43
$674K - $871K
|
2.9K
$682M
|
|
|
|
N/A
|
24.9K
$670M
|
|
|
|
N/A
|
325K
$35.9B
|
|